<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema" xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema" xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dct="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/" xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/" xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/" xmlns:cja="http://www.elsevier.com/xml/cja/schema" xmlns:ja="http://www.elsevier.com/xml/ja/schema" xmlns:bk="http://www.elsevier.com/xml/bk/schema" xmlns:ce="http://www.elsevier.com/xml/common/schema" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:cals="http://www.elsevier.com/xml/common/cals/schema" xmlns:tb="http://www.elsevier.com/xml/common/table/schema" xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema" xmlns:xlink="http://www.w3.org/1999/xlink"><rdf:RDF><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.dib.2021.107578"><dct:format>application/xml</dct:format><dct:title>Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center</dct:title><dct:creator>Matthew D. Krasowski</dct:creator><dct:creator>Anna Dolezal</dct:creator><dct:creator>Bryan W. Steussy</dct:creator><dct:creator>Michael P. Gailey</dct:creator><dct:creator>Benjamin W. Darbro</dct:creator><dct:subject><rdf:Bag><rdf:li>Anti-N-methyl-D-aspartate receptor encephalitis</rdf:li><rdf:li>Autoantibodies</rdf:li><rdf:li>Paraneoplastic syndromes</rdf:li><rdf:li>Utilization review</rdf:li><rdf:li>Voltage-gated calcium channels</rdf:li><rdf:li>Voltage-gated potassium channels</rdf:li></rdf:Bag></dct:subject><dct:description>Data in Brief 39 (2021). doi:10.1016/j.dib.2021.107578</dct:description><prism:aggregationType>journal</prism:aggregationType><prism:publicationName>Data in Brief</prism:publicationName><prism:copyright>&#169; 2021 The Author(s). Published by Elsevier Inc.</prism:copyright><dct:publisher>Elsevier Inc.</dct:publisher><prism:issn>2352-3409</prism:issn><prism:volume>39</prism:volume><prism:coverDisplayDate>December 2021</prism:coverDisplayDate><prism:doi>10.1016/j.dib.2021.107578</prism:doi><prism:url>http://dx.doi.org/10.1016/j.dib.2021.107578</prism:url><dct:identifier>doi:10.1016/j.dib.2021.107578</dct:identifier><bam:articleNumber>107578</bam:articleNumber><oa:openAccessInformation><oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus><oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-11-11T12:57:02Z</oa:openAccessEffective><oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType></oa:sponsor><oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by/4.0/</oa:userLicense></oa:openAccessInformation><cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY license.</cp:licenseLine></rdf:Description></rdf:RDF><dp:document-properties><dp:aggregation-type>Journals</dp:aggregation-type><dp:version-number>S300.1</dp:version-number></dp:document-properties><ja:article docsubtype="dat" version="5.6" xml:lang="en"><ja:item-info><ja:jid>DIB</ja:jid><ja:aid>107578</ja:aid><ce:article-number>107578</ce:article-number><ce:pii>S2352-3409(21)00853-2</ce:pii><ce:doi>10.1016/j.dib.2021.107578</ce:doi><ce:copyright type="other" year="2021">The Author(s)</ce:copyright></ja:item-info><ja:head><ce:dochead id="dchd0001"><ce:textfn id="dhtxt0001">Data Article</ce:textfn></ce:dochead><ce:title id="tte0002">Data on the utilization of paraneoplastic syndrome autoantibody testing at an academic medical center</ce:title><ce:author-group id="aut0001"><ce:author id="au0001" author-id="S2352340921008532-3e1d0e993e8b1745a70ce5fe254bdfc4" orcid="0000-0003-0856-8402"><ce:given-name>Matthew D.</ce:given-name><ce:surname>Krasowski</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="cor0001"><ce:sup loc="post">&#x204e;</ce:sup></ce:cross-ref><ce:e-address id="ead0001" type="email" xlink:href="mailto:matthew-krasowski@uiowa.edu">matthew-krasowski@uiowa.edu</ce:e-address></ce:author><ce:author id="au0002" author-id="S2352340921008532-85e1a5ab9de00826102c7b4d46f08df0" orcid="0000-0003-3821-8833"><ce:given-name>Anna</ce:given-name><ce:surname>Dolezal</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing &#x2013; original draft</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0002"><ce:sup loc="post">b</ce:sup></ce:cross-ref></ce:author><ce:author id="au0003" author-id="S2352340921008532-af1c8fc067b39810d96c7d8f55392458" orcid="0000-0002-8036-8715"><ce:given-name>Bryan W.</ce:given-name><ce:surname>Steussy</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0003"><ce:sup loc="post">c</ce:sup></ce:cross-ref></ce:author><ce:author id="au0004" author-id="S2352340921008532-74e6718599458e5fffe6bf9c84dddf08"><ce:given-name>Michael P.</ce:given-name><ce:surname>Gailey</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:cross-ref refid="aff0001"><ce:sup loc="post">a</ce:sup></ce:cross-ref><ce:cross-ref refid="aff0004"><ce:sup loc="post">d</ce:sup></ce:cross-ref></ce:author><ce:author id="au0005" author-id="S2352340921008532-5299bb6808238a2bb793ccf4dcb78f0e"><ce:given-name>Benjamin W.</ce:given-name><ce:surname>Darbro</ce:surname><ce:contributor-role role="http://credit.niso.org/contributor-roles/formal-analysis">Formal analysis</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing &#x2013; review &amp; editing</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/methodology">Methodology</ce:contributor-role><ce:contributor-role role="http://credit.niso.org/contributor-roles/supervision">Supervision</ce:contributor-role><ce:cross-ref refid="aff0005"><ce:sup loc="post">e</ce:sup></ce:cross-ref></ce:author><ce:affiliation id="aff0001" affiliation-id="S2352340921008532-cb5a3cea5855dd64db720e81b6993a7a"><ce:label>a</ce:label><ce:textfn id="cetextfn0001">Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive C-671 GH, Iowa City, IA 52242, USA</ce:textfn><sa:affiliation><sa:organization>Department of Pathology</sa:organization><sa:organization>University of Iowa Hospitals and Clinics</sa:organization><sa:address-line>200 Hawkins Drive C-671 GH</sa:address-line><sa:city>Iowa City</sa:city><sa:state>IA</sa:state><sa:postal-code>52242</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0001">aDepartment of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Drive C-671 GH, Iowa City, IA 52242, USA</ce:source-text></ce:affiliation><ce:affiliation id="aff0002" affiliation-id="S2352340921008532-5b279217b28aaafcc6b8ee8dbb19e134"><ce:label>b</ce:label><ce:textfn id="cetextfn0002">Central Oregon Pathology Consultants, Bend, OR 97701, USA</ce:textfn><sa:affiliation><sa:organization>Central Oregon Pathology Consultants</sa:organization><sa:city>Bend</sa:city><sa:state>OR</sa:state><sa:postal-code>97701</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0002">bCentral Oregon Pathology Consultants, Bend, OR 97701, USA</ce:source-text></ce:affiliation><ce:affiliation id="aff0003" affiliation-id="S2352340921008532-8b9a3f9b1aacac5e4555da549dff87fa"><ce:label>c</ce:label><ce:textfn id="cetextfn0003">Pathology Medical Services of Siouxland, PC, UnityPoint Health-St. Luke's, Sioux City, IA 51104, USA</ce:textfn><sa:affiliation><sa:organization>Pathology Medical Services of Siouxland</sa:organization><sa:organization>PC</sa:organization><sa:organization>UnityPoint Health-St. Luke's</sa:organization><sa:city>Sioux City</sa:city><sa:state>IA</sa:state><sa:postal-code>51104</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0003">cPathology Medical Services of Siouxland, PC, UnityPoint Health-St. Luke's, Sioux City, IA 51104, USA</ce:source-text></ce:affiliation><ce:affiliation id="aff0004" affiliation-id="S2352340921008532-8150710a723a138aa63fc530ef55aaf3"><ce:label>d</ce:label><ce:textfn id="cetextfn0004">Vista Pathology Laboratory, Medford, OR 97501, USA</ce:textfn><sa:affiliation><sa:organization>Vista Pathology Laboratory</sa:organization><sa:city>Medford</sa:city><sa:state>OR</sa:state><sa:postal-code>97501</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0004">dVista Pathology Laboratory, Medford, OR 97501, USA</ce:source-text></ce:affiliation><ce:affiliation id="aff0005" affiliation-id="S2352340921008532-761260c4e9186289e4c2a54d5b8c62a4"><ce:label>e</ce:label><ce:textfn id="cetextfn0005">Stead Family Department of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA 52242, USA</ce:textfn><sa:affiliation><sa:organization>Stead Family Department of Pediatrics</sa:organization><sa:organization>University of Iowa Stead Family Children's Hospital</sa:organization><sa:city>Iowa City</sa:city><sa:state>IA</sa:state><sa:postal-code>52242</sa:postal-code><sa:country>USA</sa:country></sa:affiliation><ce:source-text id="staff0005">eStead Family Department of Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA 52242, USA</ce:source-text></ce:affiliation><ce:correspondence id="cor0001"><ce:label>&#x204e;</ce:label><ce:text id="cetext0001">Corresponding author.</ce:text></ce:correspondence></ce:author-group><ce:date-received day="15" month="7" year="2021"/><ce:date-revised day="28" month="10" year="2021"/><ce:date-accepted day="10" month="11" year="2021"/><ce:abstract id="abs0001" view="all" class="author"><ce:section-title id="cesectitle0001">Abstract</ce:section-title><ce:abstract-sec id="abss0001" view="all"><ce:simple-para id="spara006" view="all">Paraneoplastic syndromes are rare conditions associated with characteristic autoantibodies produced by malignancy, although similar autoantibodies and clinical presentations may occur in the absence of any neoplasm. Testing for paraneoplastic syndromes often involves panels of autoantibody assays. While autoantibody testing may reveal or confirm actionable clinical diagnoses, inappropriate utilization of testing may be low yield and further lead to false positives that may confuse the clinical picture. There is thus opportunity to improve patient care by analyzing patterns of paraneoplastic autoantibody test utilization. The data in this article provides results from detailed retrospective review of patients tested by 7 autoantibody tests or test panels offered by two large reference laboratories in the United States. The data include 1,446 tests performed on 1,338 unique patients at an academic medical center. For all results, detailed chart review revealed main category of presenting symptoms, patient location at time of testing (either inpatient or outpatient), sex, age, whether cancer was present at the time of testing or later detected, and the specific results of the testing. The data are summarized by category of testing and specific autoantibodies.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords id="keys0001" view="all" class="keyword"><ce:section-title id="cesectitle0002">Keywords</ce:section-title><ce:keyword id="key0001"><ce:text id="cetext0002">Anti-N-methyl-D-aspartate receptor encephalitis</ce:text></ce:keyword><ce:keyword id="key0002"><ce:text id="cetext0003">Autoantibodies</ce:text></ce:keyword><ce:keyword id="key0003"><ce:text id="cetext0004">Paraneoplastic syndromes</ce:text></ce:keyword><ce:keyword id="key0004"><ce:text id="cetext0005">Utilization review</ce:text></ce:keyword><ce:keyword id="key0005"><ce:text id="cetext0006">Voltage-gated calcium channels</ce:text></ce:keyword><ce:keyword id="key0006"><ce:text id="cetext0007">Voltage-gated potassium channels</ce:text></ce:keyword></ce:keywords></ja:head></ja:article></doc:document>
